• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neurovirol . Cognitive dysfunction following COVID-19 infection

tetano

Editor, Senior Moderator
J Neurovirol


. 2022 May 26.
doi: 10.1007/s13365-022-01079-y. Online ahead of print.
Cognitive dysfunction following COVID-19 infection


Rafi Hadad[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Johad Khoury[SUP] #[/SUP][SUP] 4 5 [/SUP], Chen Stanger[SUP] 6 [/SUP], Tali Fisher[SUP] 6 [/SUP], Sonia Schneer[SUP] 4 [/SUP], Rachel Ben-Hayun[SUP] 6 [/SUP], Katherine Possin[SUP] 7 8 [/SUP], Victor Valcour[SUP] 7 8 [/SUP], Judith Aharon-Peretz[SUP] 6 [/SUP], Yochai Adir[SUP] 4 9 [/SUP]



Affiliations

Abstract

The coronavirus (COVID-19) pandemic is still evolving, causing hundreds of millions of infections around the world. The long-term sequelae of COVID-19 and neurologic syndromes post COVID remain poorly understood. The present study aims to characterize cognitive performance in patients experiencing cognitive symptoms post-COVID infection. Patients evaluated at a post COVID clinic in Northern Israel who endorsed cognitive symptoms were referred for neurologic consultation. The neurologic work-up included detailed medical history, symptom inventory, neurological examination, the Montreal Cognitive Assessment (MoCA), laboratory tests and brain CT or MRI. Between December 2020 and June 2021, 46 patients were referred for neurological consultation (65% female), mean age 49.5 (19-72 years). On the MoCA test, executive functions, particularly phonemic fluency, and attention, were impaired. In contrast, the total MoCA score, and memory and orientation subscores did not differ from expected ranges. Disease severity, premorbid condition, pulmonary function tests and hypoxia did not contribute to cognitive performance. Cognitive decline may affect otherwise healthy patients post-COVID, independent of disease severity. Our examination identified abnormalities in executive function, attention, and phonemic fluency. These findings occurred despite normal laboratory tests and imaging findings.

Keywords: Cognitive decline; Cognitive dysfunction following COVID-19 infection; Cognitive symptoms post-COVID infection; Executive dysfunction; Memory symptoms; Post-COVID; Post-COVID cognitive impairment.
 
Back
Top Bottom